Nuclear TPPII expression correlated with p53 expression in lymphoma cells [33]; for example, a short peptide-derived inhibitor that inhibited nuclear accumulation of TPPII also inhibited nuclear expression of p53 [33]. Here, TPP2 is linked to lymphoma.